Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Minzasolmin(DLX-313) is an alpha-synuclein misfolding inhibitor for the study of Parkinson's disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 279.00 | |
5 mg | In stock | $ 678.00 | |
10 mg | In stock | $ 1,090.00 | |
25 mg | In stock | $ 1,980.00 | |
50 mg | In stock | $ 3,330.00 | |
100 mg | In stock | $ 5,330.00 |
Description | Minzasolmin(DLX-313) is an alpha-synuclein misfolding inhibitor for the study of Parkinson's disease. |
Synonyms | (R)-NPT200-11, UCB0599, DLX-313 |
Molecular Weight | 425.59 |
Formula | C23H31N5OS |
CAS No. | 1802518-92-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Minzasolmin 1802518-92-8 Others (R)-NPT200-11 UCB0599 DLX-313 inhibitor inhibit